Table 4.
Completion rates of measures amongst participants in the observation and pilot randomised controlled trial phase
| Completion | Observational phase (n = 20) | Pilot RCT Phase (n = 30) | ||||
|---|---|---|---|---|---|---|
| Feedback (n = 14) | No feedback (n = 16) | |||||
| Full (100%) | Completion range | Full (100%) | Completion range | Full (100%) | Completion range | |
| Performance-based outcomes (n = 5)* | ||||||
| Baseline | n = 3 | n = 2 65–75% | n = 2 | n = 3 57–78% | n = 0 | n = 5 75–93% |
| 3 weeks | n = 0 | n = 5 55–70% | n = 0 | n = 5 50–85% | n = 0 | n = 5 62–75% |
| 12 weeks | ||||||
| Self-report outcomes (n = 5)^ | ||||||
| Baseline | n = 2 | n = 3 90–95% | n = 2 | n = 3 85–92% | n = 0 | n = 5 87–93% |
| 3 weeks | n = 0 | n = 5 65–70% | n = 0 | n = 5 78–85% | n = 0 | n = 5 75% |
| 12 weeks (n = 3) | n = 0 | n = 3 35–45% | n = 0 | n = 3 42–50% | n = 0 | n = 3 50% |
| Smartwatch activity data | ||||||
| Patient data recorded by watch and downloaded by ward staff | n = 20 | 100% | n = 14 | 100% | n = 16 | 100% |
| Smartwatch data recorded in log | n = 4 | 20% | n = 14 | 100% | n = 16 | 100% |
Completion range refers to the percentage of recruited patients whom successfully completed assessment across measures
*Grip strength left, grip strength right, 10-m walk test; MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index
^FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item)